Fundraising Fox

Biotech Startups

10,099 companies tagged Biotech, with their investors and founders.

TRex Holdings Inc.

0 investors

TrialScope

0 investors

Trialtus Bioscience

Trialus Bioscience provides protein purification products and services for laboratory and research applications.

0 investors

Trice Medical

Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.

0 investors

Trident Labs

0 investors

TriFlo Cardiovascular

0 investors

Trigr Therapeutics

0 investors

Trinity Nuclein Rd II Investors

0 investors

Trinity Nuclein Rd II QP Investors

0 investors

Trinity Nuclein Rd III Investors

0 investors

Trinity Nuclein Rd III QP Investors

0 investors

Trio Pharmaceuticals

Trio Pharmaceuticals develops dual-targeting antibody drugs to treat cancer, using its TIE-ADC and TRAILBody platforms to kill cancer cells and overcome tumor immunosuppression while reducing treatment-related toxicity. Its pipeline targets blood cancers (AML/MDS), ovarian and endometrial cancers, and triple-negative breast and non-small cell lung cancers.

0 investors

Tris Pharma

0 investors

Triton Algae Innovations

0 investors

Tropoflex

0 investors

Tropogenix

0 investors

Trovagene

0 investors

Tru Brands

0 investors

Truminim

0 investors

Truminim International

0 investors

TuHURA Biosciences Inc./NV

0 investors

Tundra Targeted Therapeutics

0 investors

Turn Medical

Turn Medical develops and manufactures the Pronova-O2 Automated Prone Therapy System, a medical device for repositioning critically ill patients to improve patient outcomes and caregiver safety. The company serves clinicians, hospitals, and clinical institutions.

0 investors

Turn Therapeutics

Turn Therapeutics develops topical therapies for skin diseases using its proprietary PermaFusion drug delivery platform. The company's lead program, GX-03, is designed to treat moderate to severe eczema by reducing IL-36 signaling and downstream inflammatory cytokines.

0 investors

Other sectors & tags